In Vitro Diagnostics Market Research Reports & Industry Analysis

... - and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in US hospitals, commercial laboratories, physician offices and ambulatory care centers. Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and ...

This new 340-page report from Venture Planning Group provides analysis of the global blood banking market, including emerging tests, technologies, ... and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S. Comprehensive analysis of the clinical significance and market needs for major blood ...

... to be made in the future, and enhances corporate ability to develop realistic contingency plans. The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact as well as five - and ten- ...

... pharmacogenomics); and cancer screening/pharmacogenomics - are forecast to grow at CAGRs of 14%, 22%, 19% and 30% respectively. Your key questions answered Which micro and nano technologies in development offer the attributes of miniat What drivers and restraints operate in the nascent market for POC ...

This new 302-page report from Venture Planning Group provides analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of coagulation testing ...

This new 178-page report from Venture Planning Group provides analysis of the global hematology and flow cytometry market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated number of hematology ...

... Brazil. In their latest research study, “In-Vitro Diagnostics Market Analysis to 2017”, RNCOS analysts identified market dynamics in various important regions to highlight ... that together constitute around 95% of the global market, have been profiled. Further, the market has been divided into eight distinct ...

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios ...

... chemistry and immunodiagnostic product suppliers and emerging market entrants.The report presents strategic profiles of 25 current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, ...

... been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal ... , Tissue Microarrays and Mass Spectroscopy Integrated Sample-to-Results Testing Market size and forecasts in the report are for manufacturer's revenues ...

... -page report from Venture Planning Group presents a comprehensive analysis of the French microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

... -page report from Venture Planning Group presents a comprehensive analysis of the German microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

... new 970-page report from Venture Planning Group comprehensive analysis of the Italian microbiology testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views ...

... -page report from Venture Planning Group presents a comprehensive analysis of the Japanese microbiology testing market, including: Major issues pertaining to the ... , and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed ...

... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

... 978-page report from Venture Planning Group presents a comprehensive analysis of the UK microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

... 1,037-page report from Venture Planning Group presents a comprehensive analysis of the US microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

... report from Venture Planning Group presents strategic analyses of major current and emerging suppliers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. ...

... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. The Clinical Chemistry and Immunodiagnostics Markets is a unique worldwide market intelligence and technology assessment study designed to help current suppliers and potential ...

... and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... -page report from Venture Planning Group presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... -page report from Venture Planning Group presents a comprehensive analysis of the German flow cytometry market, including: Major issues pertaining to the German ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... -page report from Venture Planning Group presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... page report from Venture Planning Group presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... new 146-page report from Venture Planning Group presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... new 174-page report from Venture Planning Group presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...

... ; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ... volume and sales forecasts for over 40 transfusion diagnostic tests, including NAT, by country and market segment: Blood Centers Plasma Fractionation ...

Highlights This new 430-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French ...

Highlights This new 426-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German ...

Highlights This new 412-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian ...

Highlights This new 426-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese ...

Highlights This new 425-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... . Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish ...

Highlights This new 422-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major issues ... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in ...

Highlights This new 460-page market segmentation analysis of the transfusion testing market report from Venture Planning Group including: Major ... forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, ...

... testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction ...

... report from Venture Planning Group presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...

... from Venture Planning Group presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...

... testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction of ...

This new 27-page report from Venture Planning Group provides an overview of the French infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 27 pages and 9 tables

This new 25-page report from Venture Planning Group provides an overview of the German infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 25 pages and 9 tables

This new 23-page report from Venture Planning Group provides an overview of the Italian infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 23 pages and 9 tables

This new 43-page report from Venture Planning Group provides an overview of the US infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Contains 43 pages and 9 tables

... from Venture Planning Group presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ... test volume and sales forecasts by country for the following market segments: Hospitals Commercial/Private Labs Physician Offices Public Health ...